Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383456 · ClinicalTrials.gov registry record
The Visceral Adiposity Measurement and Observation Study
A clinical trial, sponsored by Theratechnologies.
- Completed
- Registry status
- 196
- Enrollment target
NCT05383456 is a clinical trial that has completed, run by Theratechnologies. The registered enrollment target is 196 participants.
The verdict
NCT05383456 has completed, sponsored by Theratechnologies.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
The Visceral Adiposity Measurement and Observation Study
Interventions
- DIAGNOSTIC_TEST Diagnostic Test
- DRUG HIV Anti-retroviral Background Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2023-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05383456
The ClinicalTrials.gov registry entry for NCT05383456 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theratechnologies, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diagnostic Test is the first listed.
NCT05383456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05383456 about?
NCT05383456 is a clinical study titled "The Visceral Adiposity Measurement and Observation Study". The Visceral Adiposity Measurement and Observation Study
What is the current status of trial NCT05383456?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2022-04-18. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT05383456?
The interventions under investigation include: Diagnostic Test (DIAGNOSTIC_TEST), HIV Anti-retroviral Background Therapy (DRUG).
Who is sponsoring clinical trial NCT05383456?
This trial is sponsored by Theratechnologies, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.